Skip to main content
Equibles

Kathleen Bloch

CFO

Cytosorbents Corp (CTSO)

Equibles does not estimate personal net worth.

Get an email with a short summary when Cytosorbents Corp publishes a filing, an earnings call transcript or a press release.

Get CTSO alerts

About Kathleen Bloch

Kathleen Bloch is recorded as CFO at Cytosorbents Corp (CTSO). The proxy statement of Cytosorbents Corp reports total compensation of $436,423 for Kathleen Bloch in fiscal 2024, including a base salary of $262,991. Disclosed compensation is on record for 7 fiscal years. Kathleen Bloch has spoken on 17 earnings calls across 1 company, most recently for Cytosorbents Corp on August 14, 2024. Cytosorbents Corp is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Cytosorbents Corp includes Phillip Chan (CEO and Board Member), Alexander D'Amico (CFO), Peter J. Mariani (CFO) and 7 others.

Kathleen Bloch on recent calls

“Today, I will discuss our second quarter 2024 financial results, including revenues and gross margins. Additionally, I will provide an update on our working capital and cash runway.”
CFO, Cytosorbents Corp Q2 FY2024 Earnings Call ·
“I will be discussing our first quarter financial results, including revenue and gross margins, and I will also be providing an update on our working capital and cash runway.”
CFO, Cytosorbents Corp Q1 FY2024 Earnings Call ·
“Today, I will discuss our full-year and fourth quarter 2023 financial results, including revenue, gross margins. I will also be providing an update on our working capital and cash runway.”
CFO, Cytosorbents Corp Q4 FY2023 Earnings Call ·
“For the quarter ended September 30, 2023, total revenue, which includes product sales and grant revenue was $8.8 million as compared to total revenue of $8.1 million in the third quarter of 2022, an increase of approximately 9%.”
CFO, Cytosorbents Corp Q3 FY2023 Earnings Call ·
“Let's start with our first slide on second-quarter revenues. For the quarter ended June 30, 2023, total revenue, which includes product sales and grant revenue, was $9.4 million compared to total revenue of $8.5 million in the second quarter of 2022, which is an increase of approximately 11%.”
CFO, Cytosorbents Corp Q2 FY2023 Earnings Call ·

Affiliation history

Company network

Leadership on record at Cytosorbents Corp

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Cytosorbents Corp (CTSO) $262,991 $436,423
2023 Cytosorbents Corp (CTSO) $258,638 $816,084
2021 Cytosorbents Corp (CTSO) $370,428 $1,248,680
2020 Cytosorbents Corp (CTSO) $349,460 $970,871
2019 Cytosorbents Corp (CTSO) $323,025 $999,847
2018 Cytosorbents Corp (CTSO) $295,000 $953,583
2017 Cytosorbents Corp (CTSO) $275,000 $626,614

Recent activity

Show 5 earlier activities